You are invited to complete a survey on the potential barriers to accessing pre-exposure prophylaxis (PrEP) medications that are used for the prevention of human immunodeficiency virus (HIV). This survey is jointly conducted by Walgreens and Gilead Sciences, a pharmaceutical company.
Qualified participants will receive $25 USD as a physical or digital gift card for their time completing the survey.
“Overweight” and “obesity” are complex, chronic health conditions that can be caused by several factors, such as genetics (passed on from one generation to the next), environment, hormones, or other medical conditions. While nutrition and physical activity has been proven to help many in managing their weight, for some, more help may be needed. The SYNCHRONIZE studies will help doctors understand if a new treatment to help with weight loss is safe and effective among different groups of people.
PrEP is a type of prescription medication that can help you stay free from HIV and protect you if you do not have HIV but would benefit from PrEP. Preventing HIV through learning how to make PrEP more accessible to those who may benefit from it most is a critical component to the global strategy to end the HIV epidemic.
Those who meet the following criteria may be eligible:
Se le invita a completar una encuesta sobre las posibles barreras para acceder a los medicamentos de profilaxis previa a la exposición (PrEP) que se utilizan para la prevención del virus de la inmunodeficiencia humana (VIH). Walgreens y Gilead Sciences, una empresa farmacéutica, llevan a cabo esta encuesta de forma conjunta.
Los participantes que cumplan los requisitos recibirán una tarjeta de regalo, física o digital, de $25 por el tiempo que dediquen a completar la encuesta.
“Overweight” and “obesity” are complex, chronic health conditions that can be caused by several factors, such as genetics (passed on from one generation to the next), environment, hormones, or other medical conditions. While nutrition and physical activity has been proven to help many in managing their weight, for some, more help may be needed. The SYNCHRONIZE studies will help doctors understand if a new treatment to help with weight loss is safe and effective among different groups of people.
PrEP es un tipo de medicamento de venta con receta que puede ayudarle a evitar contraer el VIH y a protegerse si no tiene el VIH, pero podría obtener beneficios de PrEP. Prevenir el VIH obteniendo información sobre cómo hacer que PrEP sea más accesible a quienes más pueden beneficiarse de ella es un componente esencial de la estrategia mundial para acabar con la epidemia del VIH.
Quienes cumplan los siguientes criterios pueden ser elegibles:
Mayores de 18 años.
Los participantes de Alabama o Nebraska deben tener al menos 19 años
Personas alas que no se les haya diagnosticado el VIH.